Neuroscience · Research topic

Open research questions in Neuroinflammation and Neurodegeneration Mechanisms

1,210 gap statements mined from Neuroinflammation and Neurodegeneration Mechanisms papers in our 7.9M-paper local library, which holds 4,524 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Neuroinflammation and Neurodegeneration Mechanisms? See the ranked Biology journals.

What the literature leaves open

  • Current therapies are often constrained by limitations in timing and effectiveness. There is a need to characterize molecular events associated with ischemic injury and neuroprotection.

    Exploring key genes associated with metabolic cell death in ischemic stroke: a comprehensive analysis of single-cell, bulk transcriptome, and experimental validation · 2026 · DOI
  • The need to develop effective treatment strategies for depression that take into account the etiological heterogeneity of the disorder. The challenge of translating the findings from animal models to humans.

    Dynamic Remodeling of Dentate Gyrus Microglia Underlies Adult Depression-Like Outcomes Following Adolescent High-Fat Diet Exposure · 2026 · DOI
  • The effects of Tinosinenside A on AD-related neuroinflammation remain unclear. There is a need for further investigation of natural-product-derived therapeutic leads for AD.

    Tinosinenside A ameliorates Alzheimer’s disease-related pathology in APP/PS1 mice, accompanied by reduced neuroinflammation and altered microglial phenotype-associated marker expression · 2026 · DOI
  • The adverse effects of inflammation on memory formation have been well documented, but its contribution to the process of forgetting has been less explored. The mechanisms underlying accelerated forgetting are not well understood, and the role of the integrated stress response (ISR) in this process is unknown.

    Integrated stress response inhibition rescues inflammation-associated accelerated forgetting of recognition memory in mice · 2026 · DOI
  • The need for further research to fully understand the therapeutic potential of G. elata and its components. The challenge of translating preclinical findings to clinical applications.

    Gastrodia elata in neurological disorders: a systematic review of anti-inflammatory mechanisms and cross-disease therapeutic potential · 2026 · DOI
  • Need for improving pharmacokinetic properties and reducing systemic side effects of phytochemicals.

    Dietary phytochemicals targeting neuroinflammation: mechanisms, bioavailability and translational challenges · 2026 · DOI
  • The mechanisms of ARBD progression to advanced stages with permanent disability are not well understood. There is a need to characterize the effects of chronic heavy ethanol feeding on white matter myelin protein expression, neuroinflammation, and mTOR signaling.

    Progressive Alcohol-Related Brain Atrophy and White Matter Pathology Are Linked to Long-Term Inhibitory Effects on mTOR Signaling · 2025 · DOI
  • The lack of effective treatments for neurodegenerative diseases. The need for novel compounds with anti-inflammatory and ferroptosis-inhibiting effects. The limited understanding of the pharmacological mechanisms of compounds derived from deep-sea fungi.

    Deep-Sea-Derived Isobisvertinol Targets TLR4 to Exhibit Neuroprotective Activity via Anti-Inflammatory and Ferroptosis-Inhibitory Effects · 2025 · DOI
  • Limited research has explored whether microglia in different regions of the central nervous system possess distinct traits. The integration of microglia into brain organoids has been accomplished effectively, but continuous challenges remain that hinder the progression and broader application in the field of neurology and immunology.

    Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research · 2024 · DOI
  • The need to improve the biocompatibility and targeting properties of nanoparticles. The challenge of traversing the blood-brain barrier to deliver drugs to the brain. The need to develop novel therapeutic approaches that can improve brain tissue's ischemic state and attenuate neurological damage and dysfunction.

    Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke · 2024 · DOI
  • One challenge is the limited accessibility of the human CNS for investigations. Another challenge is the complexity of the interplay between resident innate immune cells and other cell types involved in MS.

    CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis · 2024 · DOI
  • The need for further comprehensive investigation to fully comprehend the pathogenesis of neuropathic pain. The potential of ferroptosis as a target for treating neuropathic pain is not fully explored.

    New Insight into Neuropathic Pain: The Relationship between α7nAChR, Ferroptosis, and Neuroinflammation · 2024 · DOI
  • Further studies are needed to characterize molecular events associated with ischemic injury and neuroprotection. The complex interactions between ischemic conditions and metabolic cell death pathways should be further explored. Therapeutic strategies targeting the identified genes and pathways should be developed.

    Exploring key genes associated with metabolic cell death in ischemic stroke: a comprehensive analysis of single-cell, bulk transcriptome, and experimental validation · 2026 · DOI
  • However, the mechanisms underlying selective crosstalk between microglial subtypes and distinct inhibitory neuronal subtypes remain unclear.

    Single-cell Dissection of Microglial Heterogeneity Reveals Subtype-driven Immune-metabolic Crosstalk in Major Depressive Disorder · 2026 · DOI
  • Although the precise role of neuroinflammation in the pathogenesis of AD remains incompletely elucidated, an increasing number of studies have revealed that pathological Aβ and Tau proteins are extensively involved in the neuroinflammatory process mediated by microglia activation in AD, exhibiting a complex interplay.

    Involvement and Mechanisms of Aβ and Tau in the Neuroinflammatory Response of Alzheimer’s Disease · 2026 · DOI
  • Contradictory data and mechanistic evidence were assessed for every communication pathway; knowledge gaps were identified, and specific experiments were proposed to resolve these uncertainties.

    Dysfunctional Crosstalk in Ischemic Stroke: Exploring Network Failure and Emerging Communication Pathways · 2026 · DOI
  • Although rare and common variants in ABCA7 associated with AD alter the coding sequence and are predicted to impair protein function, the precise cell-type consequences of ABCA7 deficiency remain incompletely defined.

    The Alzheimer's disease risk gene ABCA7 regulates microglial lysosomal and lipid homeostasis and promotes phagocytosis to maintain neuronal health · 2026 · DOI
  • Soluble epoxide hydrolase (sEH), which degrades anti-inflammatory epoxyeicosatrienoic acids (EETs), is elevated in the AD brain, yet how EETs restrain inflammation remains poorly understood.

    Astrocytic sEH-EET signaling regulates microglial lysosomal function and suppresses the STING-Type I interferon pathway in Alzheimer's disease · 2026 · DOI
  • Investigate the effects of HFD exposure on other brain regions and cell types. Examine the effects of other types of dietary interventions on dentate gyrus microglia and behavior. Investigate the potential therapeutic use of minocycline in preventing HFD-induced behavioral changes in humans. Examine the effects of HFD exposure on mental health outcomes in females.

    Dynamic Remodeling of Dentate Gyrus Microglia Underlies Adult Depression-Like Outcomes Following Adolescent High-Fat Diet Exposure · 2026 · DOI
  • Further investigation of Tis A as a natural-product-derived therapeutic lead for AD, - Evaluation of Tis A effects on other AD-related pathologies, - Investigation of the mechanisms underlying Tis A's effects on neuroinflammation and AD-related…

    Tinosinenside A ameliorates Alzheimer’s disease-related pathology in APP/PS1 mice, accompanied by reduced neuroinflammation and altered microglial phenotype-associated marker expression · 2026 · DOI
  • Extremely poor bioavailability, low water solubility, rapid hepatic metabolism, and rapid elimination of phytochemicals - Limited data from clinical trials for neurological disorders - Differences in dose, route of administration, disease models, metabolism, and pharmacokinetic profiles may limit direct extrapolation…

    Dietary phytochemicals targeting neuroinflammation: mechanisms, bioavailability and translational challenges · 2026 · DOI
  • Elucidate the causal relations between the alteration of astrocytes and GFAP staining, and neural processes, - Determine the mechanisms involved in GFAP's influence on the elimination of free oxidative radicals, - Investigate the role of GFAP in transport functions and its association with enzymes, - Examine the relationship between GFAP and psychiatric diseases, such…

    The relative withdrawal of GFAP—An essential component of brain evolution · 2025 · DOI
  • Investigation of repurposing drugs with anti-inflammatory properties for the treatment of epilepsy, - Study of the role of microglia-astrocyte crosstalk in neuroinflammation…

    Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs · 2024 · DOI
  • Human brain organoids are constantly arising and getting closer to the human brain, but they are still scarcely recapitulating the whole complexity of the human CNS, - The 'brain-on-a-dish' approach lacks, in most cases, a proper immune system, a vasculature system, a lymphatic system…

    CNS Resident Innate Immune Cells: Guardians of CNS Homeostasis · 2024 · DOI
  • Further comprehensive investigation to fully comprehend the pathogenesis of neuropathic pain, - The potential mechanisms that may be involved in ferroptosis, such as fluctuations in intracellular iron ion concentrations, the modulation of glutamate excitability, and lipid…

    New Insight into Neuropathic Pain: The Relationship between α7nAChR, Ferroptosis, and Neuroinflammation · 2024 · DOI

Most-cited papers in Neuroinflammation and Neurodegeneration Mechanisms

Most recent work

Find a gap in your own Neuroinflammation and Neurodegeneration Mechanisms sub-topic

This page shows what the Neuroinflammation and Neurodegeneration Mechanisms literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Neuroscience

Open questions raised by papers listed on this page include: (1) There is a need to characterize molecular events associated with ischemic injury and neuroprotection (“Exploring key genes associated with metabolic cell death in ischemic stroke: a…”, 2026); (2) The effects of Tinosinenside A on AD-related neuroinflammation remain unclear (“Tinosinenside A ameliorates Alzheimer’s disease-related pathology in APP/PS1…”, 2026); (3) The mechanisms underlying accelerated forgetting are not well understood, and the role of the integrated stress response (ISR) in this process is unknown (“Integrated stress response inhibition rescues inflammation-associated…”, 2026); (4) The mechanisms underlying selective crosstalk between microglial subtypes and distinct inhibitory neuronal subtypes remain unclear (“Single-cell Dissection of Microglial Heterogeneity Reveals Subtype-driven…”, 2026); (5) Soluble epoxide hydrolase (sEH), which degrades anti-inflammatory epoxyeicosatrienoic acids (EETs), is elevated in the AD brain, yet how EETs restrain inflammation remains poorly understood (“Astrocytic sEH-EET signaling regulates microglial lysosomal function and…”, 2026). 1,210 gap statements have been mined from Neuroinflammation and Neurodegeneration Mechanisms papers in our 7.9M-paper local library, which holds 4,524 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.